Patents by Inventor Bart Jonckx

Bart Jonckx has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POSTERIOR OCULAR FIBROSIS INHIBITION BY ANTAGONIZING PLACENTAL GROWTH FACTOR
    Publication number: 20190031762
    Abstract: The disclosure is situated in the field of ocular therapies. In particular, in some embodiments the disclosure provides antagonists of placental growth factor and related methods of use for treating, preventing, or delaying posterior ocular fibrosis. In other embodiments, the disclosure provides monospecific placental growth factor (PlGF) antagonist compositions and related methods for maintaining or improving visual acuity of a subject with an eye of which the retina is damaged.
    Type: Application
    Filed: March 10, 2017
    Publication date: January 31, 2019
    Applicant: THROMBOGENICS NV
    Inventors: Tine Van Bergen, Bart Jonckx, Jean Feyen
  • Improving trabeculectomy outcome by administering an anti-placental growth factor antibody
    Patent number: 9089552
    Abstract: The current invention relates to the improvement of trabeculectomy surgery. The improvement more specifically resides in an extended lifetime of the sclera-corneal drainage channel created by trabeculectomy surgery. The improvement is obtained by post-surgical administration of an anti-PlGF antibody or fragment thereof.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: July 28, 2015
    Assignee: ThromboGenics NV
    Inventors: Bart Jonckx, Tine Van Bergen, Ingeborg Stalmans